» Articles » PMID: 11441917

Brain T-complex Polypeptide 1 (TCP- 1) Related to Its Natural Substrate Beta1 Tubulin is Decreased in Alzheimer's Disease

Overview
Journal Life Sci
Publisher Elsevier
Date 2001 Jul 10
PMID 11441917
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The t-complex polypeptide 1 is a selective molecular chaperone in tubulin biogenesis, by that nascent tubulin subunits are bound to t-complex polypeptide 1 and released in assembly competent forms. In neurodegenerative diseases with Alzheimer pathology cytoskeletal proteins are deficient and aggregated. Therefore we examined t-complex polypeptide 1 as represented by the zeta subunit and its specific substrate beta 1 tubulin represented by a truncated product in six brain regions of nine patients with Alzheimer's disease, nine patients with Down syndrome and nine controls. We used 2 dimensional electrophoresis with in-gel-digestion and matrix-assisted laser desorption/ ionization- mass spectrometry for the separation and identification of human brain t-complex polypeptide 1 and beta 1 tubulin. When t-complex polypeptide I was related to its natural and specific substrate beta 1 tubulin, the ratio was significantly decreased in the temporal, frontal, parietal cortex and in thalamus of patients with Alzheimer's disease. In Down syndrome the t-complex polypeptide 1/beta 1 tubulin ratio was significantly increased in frontal and parietal cortex suggesting a different mechanism for aggregation of microfilament proteins e.g. beta 1 tubulin. Relatively decreased molecular chaperoning of beta 1 tubulin by t-complex polypeptide 1 may lead to misfolded tubulin aggregating and accumulating in plaques and tangles, a hallmark of Alzheimer's disease. Our contribution provides first clues for a mechanism of microtubular accumulation in Alzheimer's disease and challenges further studies on different chaperones and chaperonins in the brain of patients with neurodegenerative diseases.

Citing Articles

Revisiting the chaperonin T-complex protein-1 ring complex in human health and disease: A proteostasis modulator and beyond.

Zeng C, Han S, Pan Y, Huang Z, Zhang B, Zhang B Clin Transl Med. 2024; 14(2):e1592.

PMID: 38363102 PMC: 10870801. DOI: 10.1002/ctm2.1592.


Serum Glycoproteomics and Identification of Potential Mechanisms Underlying Alzheimer's Disease.

Kerdsaeng N, Roytrakul S, Chanprasertyothin S, Charernwat P, Chansirikarnjana S, Sritara P Behav Neurol. 2021; 2021:1434076.

PMID: 34931130 PMC: 8684523. DOI: 10.1155/2021/1434076.


Physiological and Pathological Roles of 15-Deoxy-Δ-Prostaglandin J in the Central Nervous System and Neurological Diseases.

Yagami T, Yamamoto Y, Koma H Mol Neurobiol. 2017; 55(3):2227-2248.

PMID: 28299574 DOI: 10.1007/s12035-017-0435-4.


Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population.

Lou J, Zhong R, Shen N, Lu X, Ke J, Duan J Sci Rep. 2015; 5:8194.

PMID: 25645453 PMC: 4314627. DOI: 10.1038/srep08194.


Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane.

Yamamoto Y, Takase K, Kishino J, Fujita M, Okamura N, Sakaeda T PLoS One. 2011; 6(3):e17552.

PMID: 21445266 PMC: 3060826. DOI: 10.1371/journal.pone.0017552.